FORWARD PHARMA A/S: Financial statements 2018
CVR: 28865880
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -7,608,927 and a net result of DKK -54,294,876 compared with USD 880,210,000 the year before. Equity in the 2018 report amounted to DKK 534,575,582. The solvency ratio was 99%. The company had 3 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -7,608,927
- Profit/Loss
- DKK -54,294,876
- Equity
- DKK 534,575,582
- Total Assets
- DKK 539,859,395
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 | -7.6 mio. | -54.3 mio. | 534.6 mio. | 3 |
| 2017 | 1.3 mia. USD | - | 880.2 mio. USD | 89.4 mio. USD | - |
| 2016 | - | - | 2 mio. USD | 189.7 mio. USD | - |
| 2015 | - | - | -51.1 mio. USD | 176.7 mio. USD | - |
| 2014 | - | - | -13.7 mio. USD | 238 mio. USD | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
FORWARD PHARMA A/S has published its annual report for 2017. Revenue came to DKK 1,250,000,000, and the net result was DKK 880,210,000.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.